MD Buyline Receives National Helen Yerger/L. Vann Seawell Best Article Award for 2013-14

“The New Break-Even Analysis” article was recognized for editorial achievement.

DALLAS, TX — June 25, 2014 — MD Buyline is proud to announce the Healthcare Financial Management Association (HFMA) presented Mr. James Laskaris, emerging technology analyst of MD Buyline, and Ms. Katie Regan, clinical publications manager of MD Buyline, with the national Helen Yerger/L. Vann Seawell Best Article Award for 2013-14.

The award recognizes “The New Break-Even Analysis” article, published in the December 2013 issue of hfm Magazine, for outstanding editorial achievement and contribution to the literature of healthcare professionals.

MD Buyline is proud to receive this award and recognize Mr. Laskaris and Ms. Regan for their achievements. This article came out of a need MD Buyline saw in the healthcare industry to elevate the scope and assumptions associated with the traditional break-even analysis. We are excited that the hfm readers agreed these new insights are critical elements for value analysis teams to consider when making financially viable technology acquisitions,” said Mr. David Rodriguez, vice president, marketing and solutions management of MD Buyline.

Changes in the economic and legislative environment are complicating the capital acquisition landscape. Healthcare providers need to re-evaluate the assumptions that underlie their break-even analysis and incorporate clinical aspects into their decisions. The awarded article introduces four main areas of the new break-even analysis, including cost, utilization, payment and margins, and clinical considerations.

A complimentary copy of “The New Break-Even Analysis” is available for download.


About MD Buyline 

Healthcare providers recognize MD Buyline as the leading provider of evidence-based information and research. By creating transparency and fostering consultative relationships, MD Buyline has partnered with providers for more than three decades to identify cost reduction opportunities for purchased services, consumables, capital and IT. Providers rely on MD Buyline’s data and clinical analysts for financial and clinical insight to reach long- and short-term goals. For more information, please visit, and follow MD Buyline on Twitter, @MDBuyline.